These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18431893)

  • 21. Diabetes mellitus and non-ST elevation myocardial infarction in Thai ACS Registry.
    Ratanasumawong K; Boonyaratavej S; Srimahachota S; Boonsom W; Tungsubutra W; Sanguanwong S
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():51-7. PubMed ID: 18431886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
    Dziewierz A; Siudak Z; Rakowski T; Zdzienicka J; Dykla D; Mielecki W; Dubiel JS; Dudek D
    Cardiol J; 2008; 15(5):451-7. PubMed ID: 18810721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of acute coronary syndromes in a new French coronary intensive care unit. The first four years of activity in the GRACE registry (Global Registry of Acute Coronary Events)].
    Philippe F; Larrazet F; Dibie A; Bouabdallah K; Carbognani D; Folliguet T; Czitrom D; Lagier A; Laborde F; Cohen A; Montalescot G
    Ann Cardiol Angeiol (Paris); 2005 Mar; 54(2):68-73. PubMed ID: 15828460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review].
    Husted SE; Nielsen HK
    Ugeskr Laeger; 2010 Sep; 172(37):2522-6. PubMed ID: 20836961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of the acute coronary syndrome in Germany: experiences in a German cluster of the GRACE registry].
    Tebbe U; Bramlage P; von Löwis of Menar P; Lawall H; Gaudron P; Lüders S; Klaus A; Lengfelder W; Scholz KH; Maziejewski S; Cuneo A; Hohmann V; Gulba D
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2000-5. PubMed ID: 17882737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute coronary syndrome (ACS) registry--leading the charge for National Cardiovascular Disease (NCVD) Database.
    Chin SP; Jeyaindran S; Azhari R; Wan Azman WA; Omar I; Robaayah Z; Sim KH
    Med J Malaysia; 2008 Sep; 63 Suppl C():29-36. PubMed ID: 19230244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mexican Registry of Acute Coronary Syndromes.
    García-Castillo A; Jerjes-Sánchez C; Martínez Bermúdez P; Azpiri-López JR; Autrey Caballero A; Martínez Sánchez C; Ramos Corrales MA; Llamas G; Martínez Sánchez J; Treviño AJ;
    Arch Cardiol Mex; 2005; 75 Suppl 1():S6-32. PubMed ID: 16001714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kuwait acute coronary syndromes registry: baseline characteristics, management practices and in-hospital outcomes of patients hospitalized with acute coronary syndromes in Kuwait.
    Zubaid M; Rashed WA; Saad H; Attiya A; Al-Banat BA; Ridha M; Al-Kandari MH; Baidas G; Al-Hamdan R; Zubair S; Thalib L
    Med Princ Pract; 2007; 16(6):407-12. PubMed ID: 17917438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
    Husted S; Kher A
    Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromes.
    Segev A; Strauss BH; Tan M; Buller CE; Mendelsohn AA; Langer A; Goodman SG;
    Int J Cardiol; 2008 Sep; 129(2):233-7. PubMed ID: 17976842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and outcomes of acute coronary syndrome with minimal myocardial necrosis: analysis of a large prospective registry from a non-interventional centre.
    Ray KK; Sheridan PJ; Bolton J; Clayton TC; Veitch A; Manivarmane R; Al Rifai A; Payne G; Baig W
    Int J Clin Pract; 2006 Apr; 60(4):383-90. PubMed ID: 16620349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE).
    Zubaid M; Rashed WA; Al-Khaja N; Almahmeed W; Al-Lawati J; Sulaiman K; Al-Motarreb A; Amin H; Al-Suwaidi J; Al-Habib K
    Saudi Med J; 2008 Feb; 29(2):251-5. PubMed ID: 18246236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of low-molecular-weight heparins in the management of unstable angina and non-ST elevation myocardial infarction.
    Alwi I
    Acta Med Indones; 2008 Oct; 40(4):228-32. PubMed ID: 19530369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
    Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes.
    Nicolau JC; Cohen M; Montalescot G
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):440-5. PubMed ID: 19365279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
    Antman EM; Kereiakes DJ
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
    Mukherjee D; Eagle KA
    Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice.
    Zeymer U; Gitt A; Jünger C; Koeth O; Zahn R; Wienbergen H; Gottwik M; Senges J;
    Am J Cardiol; 2006 Jul; 98(1):19-22. PubMed ID: 16784913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.
    Goodman SG; Bozovich GE; Tan M; Dos Santos A; Gurfinkel EP; Cohen M; Langer A;
    Am Heart J; 2006 Apr; 151(4):791-7. PubMed ID: 16569535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.